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Inheritance of phenotypic traits depends on two key events: replication of the determinant of that trait and
partitioning of these copies between mother and daughter cells. Although these processes are well understood for
nucleic acid–based genes, the mechanisms by which protein-only or prion-based genetic elements direct phenotypic
inheritance are poorly understood. Here, we report a process crucial for inheritance of the Saccharomyces cerevisiae
prion [PSI
þ], a self-replicating conformer of the Sup35 protein. By tightly controlling expression of a Sup35-GFP fusion,
we directly observe remodeling of existing Sup35
[PSIþ] complexes in vivo. This dynamic change in Sup35
[PSIþ] is lost
when the molecular chaperone Hsp104, a factor essential for propagation of all yeast prions, is functionally impaired.
The loss of Sup35
[PSIþ] remodeling by Hsp104 decreases the mobility of these complexes in the cytosol, creates a
segregation bias that limits their transmission to daughter cells, and consequently diminishes the efficiency of
conversion of newly made Sup35 to the prion form. Our observations resolve several seemingly conflicting reports on
the mechanism of Hsp104 action and point to a single Hsp104-dependent event in prion propagation.
Citation: Satpute-Krishnan P, Langseth SX, Serio TR (2007) Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance. PLoS Biol 5(2): e24. doi:10.
1371/journal.pbio.0050024
Introduction
The prion hypothesis was originally proposed to explain
the etiology of the transmissible spongiform encephalopa-
thies, a group of mammalian neurodegenerative diseases that
arise and spread through a protein-only mechanism: a self-
perpetuated change in the folding of a cellularly encoded
protein PrP [1,2]. The idea that a protein conformation could
encode genetic information gained additional support when
two enigmatic traits in Saccharomyces cerevisiae, [URE3] and
[PSI
þ], were identiﬁed as prions [3]. The [URE3] and [PSI
þ]
phenotypes mimic loss-of-function mutations in the URE2
and SUP35 genes, respectively, but the prion phenotypes are
epigenetic and arise when the Ure2 or Sup35 proteins
assemble into functionally compromised higher-order com-
plexes that are self-replicating [4–6]. Importantly, speciﬁc
conformations of the Ure2 or Sup35 proteins confer
heritable [URE3] and [PSI
þ] when exogenously supplied to
non-prion cells, the ultimate proof of the prion mechanism
for these traits [7–9].
The cornerstone of this protein-only mechanism is the
ability of the prion form to self-replicate by templating the
conversion of other conformers of the same protein to a like
state. This process has been modeled in vitro for both Ure2
and Sup35, providing additional support for the prion
hypothesis [10–13]. In each case, denatured recombinant
protein spontaneously assembles into ordered, b sheet–rich
ﬁbers that bind amyloid-speciﬁc dyes upon dilution from
denaturant. Remarkably, ﬁbrillization of freshly added
protein occurs at an accelerated rate in the presence of
pre-formed ﬁbers or of lysates from cells propagating the
prion form, recapitulating the self-replication process.
Although prion proteins clearly have the capacity to direct
the folding of other conformers in a deﬁned puriﬁed system,
extension of the prion hypothesis to practice becomes a
multistep endeavor within the context of a living cell (Figure
1). First, newly synthesized prion protein must acquire the
prion form, likely through its incorporation into existing
prion complexes. Second, prion complexes must be stably
maintained yet continually subdivided to yield additional
replication templates known as prion seeds or propagons.
Third, propagons must be partitioned to daughter cells in
actively dividing cultures, where they continue to direct the
conversion of newly made protein to the prion form and
ensure inheritance of the associated phenotype. Thus,
inhibition of the pathway at any point would lead to the
same outcome: prion loss (also known as curing).
Progression through this in vivo prion cycle (Figure 1) is
modulated by parallel, and sometimes competing, quality-
control pathways [14], and the interplay between these
processes has emerged as a powerful tool for dissecting the
mechanism of protein-only inheritance in vivo. Not surpris-
ingly, factors involved in the quality control of protein
folding are the largest group of characterized prion regu-
lators in yeast [15–22]. Members of both the Hsp70 (Ssa1 and
Ssb1) and Hsp40 (Ydj1) families have been implicated in
[URE3] [15–17] and [PSI
þ] [18,20–24] inheritance, but the
molecular disaggregase Hsp104 has, by far, the most
pronounced effects on fungal prion propagation.
Hsp104 is a member of the heat-inducible Clp/Hsp100
family of AAA
þ ATPases and functions as a hexamer to
resolve stress-induced aggregates [25–28]. Hsp104 is also
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PLoS BIOLOGYconstitutively expressed at low levels in logarithmically
growing yeast cultures [28]. Under these normal growth
conditions, Hsp104 is required for both the de novo
appearance and propagation of all known S. cerevisiae prions
[15,20,28–30]. Given its essential role, the mechanism by
which Hsp104 mediates protein-only inheritance has been
the subject of intense study.
In the case of [PSI
þ], deletion of Hsp104 induces prion loss
or curing [20], and strains devoid of Hsp104 function cannot
reacquire heritable [PSI
þ] [29], leading to the initial sugges-
tion that Hsp104 activity was required for Sup35 to access
and/or maintain a prion-competent intermediate form [5,20].
Contrary to this idea, [PSI
þ] can be induced de novo in the
absence of Hsp104 if Sup35 is overexpressed along with a
second prion protein such as New1 or Rnq1, suggesting that
the Hsp104 requirement for de novo [PSI
þ] formation is
actually an indirect effect through the propagation of a co-
prion [30,31]. In line with this model, newly synthesized
Sup35 can join existing complexes upon Hsp104 inhibition in
vivo [32], and full-length Sup35, or a fragment of the protein
comprising only the prion determining domain (NM), can
assemble into amyloid ﬁbers in the absence of Hsp104 in vitro
[10,11]. However, Hsp104 does accelerate the spontaneous
assembly of Sup35 ﬁbers in vitro [13,33,34] and, at early time
points in ﬁbrillization reactions, promotes the steady-state
accumulation of a Sup35 conformer that immunoreacts with
an antibody speciﬁc for amyloidogenic intermediates [33].
Thus, although Hsp104 may not be absolutely required for
conversion of Sup35 to the prion state, its activity may
increase the efﬁciency of this process.
In addition to a potential role in protein-state replication,
Hsp104 has been linked to the generation of additional [PSI
þ]
propagons, a process most frequently described as fragmen-
tation of prion complexes [6,35]. Such fragmentation would
increase the converting capacity of the existing steady-state
pool of Sup35 by distributing the protein among a greater
number of complexes and would also facilitate the trans-
mission of these prion templates to daughter cells upon
division. In support of this model, prion loss upon inhibition
of Hsp104 is progressive in dividing cultures, with prefer-
ential retention of propagons in mother cells [36,37].
Reactivation of Hsp104 in these cells prior to prion loss
results in a cell division– and protein synthesis–independent
increase in propagon number, suggesting an Hsp104-medi-
ated change in existing Sup35 [32,37]. Although the bio-
chemical nature of propagons is currently unknown, the
steady-state size of Sup35 complexes is larger in cultures
upon Hsp104 inhibition, consistent with a block to Hsp104-
dependent fragmentation [38,39], and recent in vitro studies
report the direct fragmentation of Sup35 or NM ﬁbers by
Hsp104 [33,34].
Despite these dynamic changes in Sup35 physical state
during the prion cycle, existing prion complexes must remain
sufﬁciently stable at steady state to maintain and transmit the
prion phenotype. Recent reports, employing Sup35 or NM
fusions to the green ﬂuorescent protein (GFP) have suggested
that Sup35 prion complexes are inherently unstable [40] and
that Hsp104 is required to maintain the integrity of these
complexes [41]. Consistent with this latter point, prion loss
upon Hsp104 inhibition was reported in the absence of cell
division, suggesting that curing occurs through the disassem-
bly of existing prion oligomers [41]. However, these observa-
tions are at odds with previous reports. For example,
resolubilized Sup35 is not biochemically detectible upon
Hsp104 inhibition in [PSI
þ] cultures [32], and [PSI
þ] curing by
loss of Hsp104 does not occur in non-dividing, stationary
phase cultures [36,41].
Does Hsp104 actually mediate each step of the [PSI
þ] prion
cycle in vivo, or does the interdependency of these events
complicate interpretation of the available experimental
observations? To resolve this issue, we have systematically
probed each individual step in the [PSI
þ] prion cycle in vivo
(Figure 1) by monitoring the Hsp104-dependent dynamics of
either newly made or existing Sup35 in single live cells and
correlating these changes in protein state to transitions in the
prion phenotype. Our observations resolve many controver-
sies in the literature and support a model in which Hsp104
acts at a single point in the [PSI
þ] prion cycle to remodel
existing prion complexes. In the absence of this event, Sup35
complexes increase in size and decrease in mobility. As a
result, these complexes are inefﬁciently transmitted to
daughter cells, and newly synthesized Sup35 accumulates in
a soluble form when the number of pre-existing oligomers
becomes limiting.
Results
Sup35-GFP
[psi ] Efficiently Joins Existing Sup35
[PSIþ]
Complexes in the Absence of Hsp104 Function
[PSI
þ] is dominant in genetic crosses between [PSI
þ] and
non-prion [psi
 ] haploids [42], and this dominance is
established immediately upon cytoplasmic mixing through
conversion of soluble Sup35 (Sup35
[psi ]) to an oligomerized
form (Sup35
[PSIþ]) [43]. We took advantage of this mating
system to address the molecular mechanism by which Hsp104
mediates protein-only inheritance in vivo. For these experi-
ments, we introduced Sup35-GFP
[psi ], a fully functional
Sup35/GFP fusion [43], and untagged Sup35
[PSIþ] into the
same cell by mating. The fate of existing Sup35-GFP
[psi ] in
Author Summary
The inheritance of phenotypic traits (the observable characteristics
of the organism) is a fundamental process in biology. Most
phenotypes are controlled by a cell’s genes, and a particular
phenotype becomes heritable when this underlying genetic
information is copied and transmitted to progeny. In contrast,
another group of phenotypes appears to be inherited through a
protein-only, or prion, mechanism in which the structure of a
protein rather than its sequence is the molecular determinant of the
phenotype. It is thought that the presence of a prion in a cell forces
conversion of a normal cellular protein into a differently folded
shape (the prion form), which simultaneously deprives the cell of the
protein’s normal function and causes the prion-folded protein to
aggregate within the cell. However, prion inheritance (how prions
are passed down to daughter cells) remains poorly understood.
Using the yeast prion [PSI
þ] as a model system, we have
elucidated a process necessary for protein-only inheritance. Here
we show that the molecular chaperone Hsp104, a factor necessary
for the inheritance of all known yeast prions, plays a single primary
role in generating additional templates for protein-state replication.
In the absence of this activity, existing prion templates are
inefficiently transferred to daughter cells. As a consequence, the
rate of protein-state replication is greatly decreased, and the
protein-based phenotype is progressively lost.
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ˇ Hsp104 Remodels Existing Prion Complexesthe absence of new synthesis and in the presence or absence
of Hsp104 function was then monitored in isolated zygotes
(Figure 2). For these experiments, Hsp104 was selectively
inactivated below the threshold of activity necessary for [PSI
þ]
propagation in either of two ways. First, an Hsp104 variant,
containing lysine-to-threonine substitutions in Hsp1049s two
nucleotide-binding domains (HSP104K218TK620T, hereafter
KTKT), w a se x p r e s s e da sad o m i n a n tn e g a t i v em u t a n t
[5,20,26]. Second, Hsp1049s ATPase activity was reversibly
inhibited by guanidine hydrochloride (GdnHCl) [44–46].
In [psi
 ] cells, Sup35-GFP is evenly distributed throughout
the cytoplasm in a diffuse pattern. Sup35-GFP
[psi ] retains this
pattern upon mating to an unmarked [psi
 ] cell (Figure 2A),
but coalesces into distinct cytoplasmic foci upon encounter-
ing Sup35
[PSIþ] (Figure 2B) [43]. When similar matings are
performed upon Hsp104 inhibition, diffuse Sup35-GFP
[psi ]
ﬂuorescence also coalesces into foci (Figure 2B). To rule out
the possibility that Sup35-GFP
[psi ] changes form before
Hsp104 inactivation, we photobleached existing Sup35-GFP
inþ/KTKT zygotes and monitored the ﬂuorescence pattern of
newly synthesized Sup35-GFP (Figure S1). Under these
conditions, ﬂuorescence again coalesces; thus, Sup35
[psi ]
can join existing Sup35
[PSIþ] complexes via an Hsp104-
independent mechanism, an observation consistent with
previous centrifugation studies [32].
Sup35istheyeasthomologofeukaryoticreleasefactor3[47],
and Sup35
[psi ] incorporation into existing Sup35
[PSIþ] com-
plexes immediately and quantitatively inactivates the protein
and induces a translation termination defect [43]. Since the
persistenceofminutequantitiesofsolubleSup35in[PSI
þ]cells
is sufﬁcient to dominantly reverse the [PSI
þ] phenotype by
supporting accurate translation termination [43], we followed
accumulation of nonsense codon readthrough-dependent
expression of a red ﬂuorescent protein (DsRed) in zygotes as
ameasureoftheefﬁciencyofSup35
[psi ]oligomerizationinthe
presence or absence of Hsp104 (Figure 2). Although read-
throughwasnotdetectedin[psi
 ]zygotes(Figure2A),the[PSI
þ]
phenotype was apparent in some [PSI
þ] 3 [psi
 ]z y g o t e s
independent of Hsp104 activity (Figure 2B). Given the
sensitivity of this single-cell readthrough assay to soluble
Sup35 [43], the appearance of red ﬂuorescence in Hsp104-
inactivated zygotes indicates the quantitative incorporation of
Sup35
[psi ] into existing Sup35
[PSIþ] complexes in these cells.
Although Sup35-GFP
[PSIþ] foci are detected in all [PSI
þ] 3
[psi
 ] zygotes independent of Hsp104 activity, the percentage
of these zygotes displaying the prion phenotype is affected by
disaggregase function. In wild-type strains, only 80% of
zygotes express DsRed within one cell division of mating, and
this percentage is further decreased in Hsp104-inactivated
zygotes (58% KTKT, 28% GdnHCl). Two previous studies
provide possible explanations for this observation. First,
GdnHCl has been shown to alter the efﬁciency of translation
termination independent of [PSI
þ] [48]. Second, individual
cells of a homogenous culture are known to fall within a
broad range of propagon counts [37], and the penetrance of
the [PSI
þ] phenotype in mating reactions likely reﬂects
differences in converting capacity due to this range. We
suggest that loss of Hsp104 exacerbates this cell-to-cell
variation in converting capacity by blocking the generation
of additional conversion templates (see below), as previously
suggested [6,35,36].
Existing Sup35
[PSIþ] Complexes Become Immobile upon
Hsp104 Inhibition
Although Sup35-GFP
[psi ] incorporation into existing
Sup35
[PSIþ] complexes is Hsp104-independent, we noted a
difference in the appearance of Sup35-GFP foci in zygotes
resulting from crosses between unmarked [PSI
þ] cells and
[psi
 ] cells expressing Sup35-GFP in the presence or absence
of Hsp104 function. In comparison with wild-type zygotes,
Hsp104-inactivated zygotes contained brighter, more distinct
foci (Figure 2B). This effect was prion dependent, as Hsp104
activity did not alter Sup35-GFP intensity in [psi
 ] 3 [psi
 ]
zygotes (Figure 2A). However, this Hsp104-dependent dis-
tinction in the appearance of Sup35-GFP foci was lost when
the fusion protein was expressed in the [PSI
þ] rather than the
[psi
 ] mating partner (Figure 2C). These observations are
consistent with a model in which the Hsp104-independent
incorporation of Sup35-GFP
[psi ] into Sup35
[PSIþ] complexes is
rapidly followed by an Hsp104-dependent change in these
oligomers, a process more easily visualized following the
addition of a bolus of ﬂuorescently marked Sup35 (Figure 2B).
To directly test the idea that Sup35
[PSIþ] complexes become
altered upon Hsp104 inactivation, we probed the physical
state of existing Sup35-GFP
[PSIþ] with ﬂuorescence recovery
Figure 1. The In Vivo Prion Cycle Is a Multistep Pathway
Existing prion complexes (black ball and loop) replicate by stimulating
the conversion of either newly synthesized or non-prion conformer of
the protein (gray ball and stick) to the prion form (black and gray ball
and loop, step 1). Prion complexes must be stably maintained (step 2),
but continually divided to generate new prion templates for additional
rounds of protein-state replication (step 3). The smaller complexes
generated by this division are efficiently transmitted to daughter cells
(step 4).
doi:10.1371/journal.pbio.0050024.g001
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ˇ Hsp104 Remodels Existing Prion Complexesafter photobleaching (FRAP) experiments. In wild-type
zygotes, Sup35-GFP
[PSIþ] was highly mobile, with 50% of the
ﬂuorescence recovered within 1 s (Figure 3A). Upon Hsp104
inactivation by KTKT (Figure 3A) or by GdnHCl treatment
(Figure S2), Sup35-GFP
[PSIþ] foci became largely immobile,
with no recovery detected by 8 s. In contrast, Sup35-GFP
[psi ]
recovery was rapid and Hsp104 independent (Figure 3B),
indicating that Hsp104 speciﬁcally altered the biophysical
properties of Sup35-GFP
[PSIþ].
Hsp104 Remodels Existing Sup35-GFP
[PSIþ] Complexes
Given the change in Sup35-GFP
[PSIþ] mobility upon
inhibition of Hsp104, we reasoned that the dynamics of
existing particles could be altered in these cells. To test this
idea, we continued to monitor existing Sup35-GFP
[PSIþ] as the
zygotes formed microcolonies. In wild-type [PSI
þ] 3 [psi
 ]
crosses, Sup35-GFP
[PSIþ] foci became undetectable in small
microcolonies (Figure 4A), as previously reported for the
single ﬂuorescent focus formed by a highly expressed NM-
GFP fusion [40]. In contrast, Sup35-GFP
[PSIþ] foci remained
visible in Hsp104-inactivated [PSI
þ] 3 [psi
 ] microcolonies
(Figure 4B and 4C). This persistence of existing complexes
was not simply a consequence of increased ﬂuorescence
intensity in cells with diminished Hsp104 function. When a
similar mating was performed but with Sup35-GFP expressed
in the [PSI
þ] partner, the ﬂuorescence intensity of foci was
Hsp104 independent (Figure 2C), but again, foci only
remained detectable in microcolonies with inactive Hsp104
(Figure S3). Thus, Hsp104 appears to stimulate turnover of
existing Sup35-GFP
[PSIþ] complexes.
What is the molecular basis of this loss in Sup35-GFP
ﬂuorescence? Hsp104-dependent degradation or remodeling
(Figure 4D) of existing Sup35-GFP are two possibilities. To
test the former idea, we monitored the metabolic stability of
Figure 2. Efficient Incorporation of Sup35-GFP
[psi ] into Existing
Sup35
[PSIþ] Complexes Is Hsp104 Independent
(A) MATa [psi
 ] haploids expressing untagged SUP35 from its endoge-
nous locus, SUP35-GFP (green) from PMFA1 and GST(UGA)DsRED from PGPD
were mated to MATa [psi
 ] haploids constitutively expressing untagged
SUP35 (gray) in the presence or absence of functional Hsp104 as shown
in the schematic diagram (top). The Sup35-GFP and DsRed fluorescence
patterns were then examined in isolated zygotes. Since PMFA1 is
repressed upon mating [43], green fluorescence is derived from existing
Sup35-GFP. Images of a representative zygote (n   5) from a wild-type
cross (SY874374D-694 MATa; left), from a cross in which the MATa [psi
 ]
mating partner contained a KTKT chromosomal replacement (SY876 3
74D-694 MATa; middle) or from a wild-type cross (SY874 3 74D-694
MATa) in the presence of GdnHCl (right) are shown.
(B) MATa [psi
 ] haploids constitutively expressing untagged SUP35 and
GST(UGA)DsRED, and SUP35-GFP (green) from PMFA1 were mated to MATa
[PSI
þ] haploids constitutively expressing untagged SUP35 (gray dots) in
the presence or absence of functional Hsp104 as shown in the diagram
(top). Sup35-GFP and DsRed fluorescence were examined in isolated
zygotes (n¼50). Images of representative zygotes from a wild-type cross
(SY874 3 74D-694 MATa; left), from a cross in which the MATa [psi
 ]
mating partner contained a KTKT chromosomal replacement (SY876 3
74D-694 MATa; middle), or from a wild-type cross (SY874 3 74D-694
MATa) in the presence of GdnHCl (right) are shown.
(C) MATa [PSI
þ]P MFA1 SUP35-GFP haploids were mated to MATa [psi
 ]
haploids constitutively expressing SUP35 (gray) in the presence or
absence of Hsp104 function, as indicated in the diagram (top). Images of
a representative zygote (n   13) from a wild-type cross (SY5973SY582;
left), from a cross in which the MATa [psi
 ] mating partner contained a
KTKT chromosomal replacement (SY5973SY776 middle), or from a wild-
type cross in the presence of GdnHCl (SY597 3 SY582; right) are shown.
The formation of zygotes was confirmed by sporulation (unpublished
data).
doi:10.1371/journal.pbio.0050024.g002
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þ] and [psi
 ] cells in the presence or
absence of Hsp104 function. Sup35-GFP accumulates to
similar levels under all conditions at steady state as
determined by Western blotting of lysates following SDS-
PAGE (Figure 5A, time 0). These levels do not change over a
1-h time course following the addition of cycloheximide to
inhibit new Sup35-GFP synthesis (Figure 5A). In contrast, the
short-lived Mata2 protein is rapidly lost from yeast lysates
following cycloheximide inhibition (Figure S4). These data
together indicate that Sup35-GFP is stable and that its half-
life is unaltered by Hsp104 activity.
Given these observations, we next considered the alternate
explanation: Hsp104-dependent remodeling of Sup35-
GFP
[PSIþ] complexes. In this scenario, existing Sup35-GFP
[PSIþ]
complexes are fragmented into smaller pieces, which incor-
porate newly made, untagged Sup35 (Figure 4D). Although
the initial and the remodeled complexes will be of similar
size, their ﬂuorescence intensities will be distinct since each
contains a different ratio of GFP-fused and untagged Sup35
(Figure 4D). To test this idea, we monitored FRAP, a
parameter inﬂuenced by diffusion rate and, therefore,
particle size [49], in wild-type [PSI
þ] zygotes and in their
daughters (Figure 5B and 5C). Sup35-GFP
[PSIþ] ﬂuorescence
recovered with similar half-times in both cells (;1s ) ,
consistent with an Hsp104-dependent remodeling of existing
prion complexes.
Loss of Hsp104-Dependent Remodeling Limits Both
Sup35-GFP
[PSIþ] Transmission to Daughter Cells and the
Subsequent Incorporation of Newly Synthesized Prion
Protein
In addition to persistence of Sup35-GFP
[PSIþ] foci in
Hsp104-inactivated cells, we also noted a segregation bias
(Figure 4B and 4C). Occasionally, the originating zygote could
be identiﬁed in the microcolony by its characteristic shape
(Figure 4B, outline). In these instances, we observed a large
number of foci retained in zygotes (Figure 4B, arrowhead)
and immediately adjacent cells, with progressively fewer foci
in cells at the periphery. Thus, the decreased mobility of
Sup35-GFP
[PSIþ] complexes in Hsp104-inactivated cells (Fig-
ure 3A) correlated with inefﬁcient transfer of these com-
plexes to daughters.
What consequence does biased segregation of existing
Sup35-GFP
[PSIþ] complexes have on conversion of newly made
prion protein? To answer this question, we monitored Sup35-
GFP ﬂuorescence in Hsp104-inactivated [psi
 ]3[PSI
þ] zygotes
and their daughters, which continued to synthesize the fusion.
In contrast to microcolonies that no longer express Sup35-
GFP (Figure 4B and 4C), diffuse ﬂuorescence was detected in
Hsp104-deﬁcient daughter cells constitutively synthesizing
Sup35-GFP (Figure 6A and 6B). Consistent with this obser-
vation, a rapidly recovering pool of Sup35-GFP was detected
by FRAP in cells constitutively expressing the fusion upon
prolonged exposure to GdnHCl (;0.3 s for 50% recovery;
Figure 6C). Accumulation of soluble Sup35-GFP in Hsp104-
deﬁcient microcolonies starkly contrasts with the quantitative
incorporation of soluble Sup35-GFP into Sup35
[PSIþ] com-
plexes in zygotes (Figure 2B), likely reﬂecting a difference in
the number of existing prion complexes in the two conditions
[37]. Thus, individual prion complexes must have a ﬁnite
conversion capacity in the absence of Hsp104 function.
Static Sup35-GFP
[PSIþ] Complexes Remain Substrates for
Hsp104-Dependent Remodeling
Prion loss or curing by inactivation of Hsp104 is a
reversible process provided that Hsp104 is reactivated in
cells containing a limiting threshold of propagons [36]. How
is efﬁcient prion propagation restored to these cells? Based
on our observations above, remodeling of existing static
Sup35
[PSIþ] complexes upon Hsp104 reactivation is one
possibility. To test this idea, we isolated zygotes resulting
from a cross between [psi
 ] cells expressing Sup35-GFP from
PMFA1 and unmarked [PSI
þ] cells on solid medium containing
GdnHCl. Under these conditions, the zygotes do not continue
to express the fusion [43]. These zygotes were then allowed to
form microcolonies in the presence of GdnHCl, which were
subsequently divided into two parts. One portion was
retained on GdnHCl-containing medium (Figure 7, left),
whereas the other was transferred to medium lacking
GdnHCl (Figure 7, right). Fluorescent foci persisted in cells
immediately after transfer to medium containing or lacking
GdnHCl (Figure 7, time 0). Although continued treatment
with GdnHCl preserved the integrity of existing complexes
even in cells containing small numbers of foci (Figure 7, left),
existing Sup35-GFP foci quickly resolved in cells transferred
to medium lacking GdnHCl (Figure 7, right). Thus, immobile
aggregates, which accumulate in GdnHCl-treated [PSI
þ] cells,
remain substrates for Hsp104-dependent remodeling.
Figure 3. Hsp104 Inhibition Renders Sup35-GFP
[PSIþ] Complexes
Immobile
(A) FRAP time courses for Sup35-GFP
[PSIþ] in wild-type (SY360 3 SY581;
black circles) and in þ/KTKT (SY893 3 SY581; white squares) zygotes are
shown (n ¼ 6). The recovery half-time for the wild-type zygote is 0.92 s
(R
2 ¼ 0.85).
(B) FRAP time courses for Sup35-GFP
[psi ] in wild-type (SY360 3 SY582;
black circles, n ¼5) and in þ/KTKT (SY8933SY582; white squares, n ¼6)
zygotes are shown. The recovery half-time for the wild-type zygote is
0.47 s (R
2¼0.85) and for theþ/KTKT zygote is 0.7 s (R
2¼0.89). The black
arrow marks the bleach point. Error bars represent standard error of the
mean.
doi:10.1371/journal.pbio.0050024.g003
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ˇ Hsp104 Remodels Existing Prion ComplexesIs the resolution of these static Sup35-GFP
[PSIþ] complexes
upon Hsp104 reactivation relevant for the [PSI
þ] prion cycle?
To test this idea, we also monitored the phenotype of the
same cells upon removal of GdnHCl from the medium by
assaying the nonsense codon readthrough-dependent expres-
sion of DsRed. Remodeling of existing Sup35-GFP foci
correlated with a phenotypic switch from accurate trans-
lation termination ( DsRed) to the readthrough of stop
codons (þDsRed; Figure 7), indicating the rapid inactivation
of excess soluble Sup35. Thus, static Sup35-GFP
[PSIþ] com-
plexes preserve their capacity to direct the efﬁcient incor-
poration of soluble Sup35
[psi ],b u to n l yw h e nH s p 1 0 4
function is restored.
Prion Complexes Become Mildly Toxic upon Loss of
Hsp104 Function
Given their relative immobility, Sup35
[PSIþ] complexes
present in Hsp104-deﬁcient cells may have detrimental
Figure 4. Hsp104 Inhibition Blocks Sup35-GFP
[PSIþ] Remodeling and Creates a Segregation Bias for Sup35-GFP Complexes
MATa [psi
 ] haploids expressing untagged SUP35 and SUP35-GFP from PMFA1 were mated to MATa [PSI
þ] haploids constitutively expressing untagged
SUP35 in the presence or absence of functional Hsp104. For each cross, a zygote (left) and a microcolony derived from that zygote (right) are shown.
(A) Representative images from a wild-type cross (SY360 3 SY581) are shown (n ¼ 10).
(B) Shown are representative images (n ¼ 5) from a KTKT 3 wild-type cross (SY876 3 SY581). The originating zygote is outlined in the DIC image and
marked with an arrow in the microcolony.
(C) Shown are representative images (n ¼ 6) of a wild-type cross (SY360 3 SY581) in the presence of GdnHCl.
(D) A model for Hsp104-dependent remodeling of prion complexes. Soluble Sup35-GFP
[psi ] (green ball and stick) is remodeled to the prion form (black
and green ball and loop) upon encountering Sup35
[PSIþ] in an Hsp104-independent process. These complexes are rapidly fragmented by Hsp104 (white
hexamer) to smaller complexes, which then efficiently incorporate soluble Sup35
[psi ] (black ball and stick), effectively redistributing existing Sup35-
GFP
[PSIþ].
doi:10.1371/journal.pbio.0050024.g004
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the subcellular localization of a fusion between the stress-
responsive transcription factor Msn2 and GFP. Msn2-GFP
resides in the cytoplasm in unstressed cells, but in response to
stress stimuli, it translocates into the nucleus where it induces
expression of genes containing stress-response elements in
their promoters [50]. In contrast to ethanol-treated cultures,
[PSI
þ] and [psi
 ] cultures treated with GdnHCl retained Msn2-
GFP in the cytoplasm (Figure S5), indicating that inactivation
of Hsp104 did not produce an Msn2-mediated response in
vivo.
Although GdnHCl treatment does not activate a stress
response in [PSI
þ] cultures (Figure S5), it does alter the cell-
division cycle. In the presence of GdnHCl, [PSI
þ]c e l l s
produce their ﬁrst daughter more slowly than untreated
cells, whereas GdnHCl treatment had no effect on the
division time of [psi
 ] cells (Table 1). This doubling-time
extension could arise either from an interaction of GdnHCl
with the prion phenotype or with prion complexes. Nonsense
suppression, however, is not the underlying cause of this
effect since expression of a Sup35 deletion mutant (DNM),
which restores accurate termination without interfering with
prion propagation by full-length Sup35 [51], does not reverse
the doubling-time extension (3.7 6 1.1 h). In contrast, we
noted a correlation between doubling time and propagon
number: cells with shorter doubling times (,2.75 h) tended to
have fewer propagons than those with longer doubling times
(Figure 8). Consistent with this idea, the [PSI
þ]- and GdnHCl-
dependent doubling-time extension was most severe for
formation of ﬁrst daughters, as subsequent daughters were
produced at more similar rates in the presence and absence
of GdnHCl (Table 1). Thus, cell division, and perhaps the
corresponding small decrease in the number of prion
complexes (Figure 4B and 4C), at least partially alleviates
the detrimental effect of inhibiting Hsp104 in [PSI
þ] cells.
Discussion
Together, our in vivo studies probe the molecular
mechanism by which Hsp104 mediates propagation of the
Sup35/[PSI
þ] prion. We suggest that Hsp104 acts at a single
point in the prion cycle to remodel existing Sup35
[PSIþ]
complexes (Figure 1). By tightly regulating expression of
Sup35-GFP, we provide direct evidence for this event: the
decreased ﬂuorescence of existing Sup35-GFP
[PSIþ] in wild-
type microcolonies (Figure 4). Despite this change in
ﬂuorescence, the protein persists (Figure 5A) and remains
assembled in complexes (Figure 5C). Because Sup35-GFP
[PSIþ]
foci remain uniformly detectable in wild-type [PSI
þ] cells that
constitutively express the fusion [43], we interpret our
observations as a redistribution of existing Sup35-GFP
molecules to new complexes containing an excess of
untagged Sup35 (Figure 4D), providing direct experimental
support in vivo for fragmentation [6,35].
In the absence of Hsp104-dependent remodeling of Sup35-
GFP
[PSIþ] complexes, a number of crucial events in the [PSI
þ]
Figure 5. Loss of Sup35-GFP
[PSIþ] Fluorescence in Wild-Type Cells Corresponds to Redistribution of Existing Fusion Protein to New Prion Complexes
(A) The metabolic stability of Sup35-GFP was analyzed in [PSI
þ] (SY81) or [psi
 ] (SY87) yeast lysates upon inhibition of new protein synthesis with
cycloheximide. An anti-Sup35 immunoblot is shown along with an anti-Pgk1 immunoblot of the same membrane as a control for loading.
(B) Shown are representative images (n¼7) of a wild-type zygote (SY3603SY581) constitutively expressing untagged SUP35 from its endogenous locus
(left image) and of the same zygote following the formation of a second daughter and first granddaughter (right image). The Sup35-GFP in these cells is
that existing at the time of mating as described in Figure 2A.
(C) FRAP recovery curves for a wild-type zygote (SY360 3 SY581; black circles) and its daughter (white circles), as described in (B), are shown. The
respective recovery times are 0.92 s (R2 ¼ 0.85) and 0.95 s (R2 ¼ 0.84).
doi:10.1371/journal.pbio.0050024.g005
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[PSIþ] com-
plexes increase in size, initially detected as brighter Sup35-
GFP ﬂuorescence (Figure 2B). By separately expressing
Sup35-GFP in either [PSI
þ]o r[ psi
 ] cells and inhibiting
fusion protein synthesis upon mating, we unambiguously link
this change to incorporation of soluble Sup35-GFP
[psi ] into
existing complexes (Figure 2). Importantly, when [PSI
þ]
complexes are marked with Sup35-GFP prior to mating, no
change in ﬂuorescence intensity is detected upon Hsp104
inhibition, indicating that existing complexes do not laterally
associate to form larger particles (Figure 2C). Thus, the
number of Sup35-GFP
[PSIþ] complexes becomes static when
Hsp104 activity is lost, as previously predicted in mathemat-
ical models of curing [36,37].
The increase in ﬂuorescence intensity of Sup35-GFP
[PSIþ]
complexes also correlates with a decrease in their mobility
(Figure 3). Although this relative immobility is immediately
apparent upon zygote formation when a large bolus of
soluble Sup35 incorporates (Figure 3), the decreased mobility
arises over time in GdnHCl-treated haploids as newly
synthesized Sup35 continues to join complexes (Video S1
and unpublished data). In either case, this immobility
provides a possible molecular explanation for the diminished
transmission of propagons to daughter cells (Figure 4) [37,39]
and the consequential decrease in the efﬁciency of incorpo-
ration of soluble Sup35
[psi ] (Figure 6) [32].
Can our observations of Sup35-GFP
[PSIþ] dynamics in vivo
explain the behavior of heritable prion particles? Several
lines of evidence suggest that Sup35-GFP
[PSIþ] foci are a
robust proxy for propagons. First, Sup35-GFP is fully func-
tional in translation termination, accumulates in cytoplasmic
foci only in [PSI
þ] cells, supports [PSI
þ] propagation as the
only copy of Sup35, and is regulated by Hsp104 levels in a
manner that is indistinguishable from wild-type Sup35 [43].
Second, mathematical models of propagon dynamics upon
Hsp104 inhibition predict a block in replication of these
heritable units and their subsequent dilution by cell division
[36]. The changes in Sup35-GFP foci that we observed upon
Hsp104 inhibition (Figures 2–4 and 7) provide direct
experimental support at the single-cell level for these
predictions: Sup35-GFP
[PSIþ] foci become static upon
Hsp104 inhibition, and their reduced mobility correlates
with an inefﬁcient transfer to daughter cells (Figures 3 and 4).
Third, genetic analyses of propagon transmission revealed a
Figure 6. Newly Synthesized Sup35-GFP Is Inefficiently Incorporated into
Limiting Prion Complexes Resulting from Hsp104 Inhibition and Cell
Division
(A) A MATa [psi
 ] haploid with KTKT and SUP35GFP chromosomal
replacements (SY751) was mated to a MATa [PSI
þ] haploid constitutively
expressing SUP35 (SY581) as shown in the diagram (top). Representative
images of a zygote and microcolony derived from this zygote are shown
(n ¼ 7).
(B) A MATa [psi
 ] haploid with a SUP35GFP chromosomal replacement
(SY87) was mated to a MATa [PSI
þ] haploid constitutively expressing
SUP35 (SY581) in the presence of GdnHCl as shown in the diagram.
Representative images of a zygote and microcolony derived from this
zygote are shown (n ¼ 7). Under these conditions, the isolated zygote
(left, [A] and [B]) continues to express Sup35-GFP, but lacks functional
Hsp104.
(C) FRAP recovery curves for [psi
 ] (SY360, white squares), [PSI
þ] (SY597,
black circles) and [PSI
þ] cells after treatment with GdnHCl for 16–24 h
(SY597, gray circles), which all constitutively express Sup35-GFP, are
shown. The respective recovery times are: 0.33 s (R
2 ¼ 0.93), 1.16 s (R
2 ¼
0.95), and 0.39 s (R
2 ¼ 0.79).
doi:10.1371/journal.pbio.0050024.g006
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prion seeds than their daughters [37]. The preferential
accumulation of existing Sup35-GFP
[PSIþ] in zygotes and their
immediate progeny mirrors propagon behavior upon divi-
sion (Figure 4). Fourth, propagon numbers increase inde-
pendently of cell division and protein synthesis upon
reactivation of Hsp104 [32,37]. In line with this observation,
static Sup35-GFP
[PSIþ] complexes are rapidly resolved co-
incidently with the bulk inactivation of soluble Sup35 upon
removal of GdnHCl from the medium (Figure 7). The close
alignment of our observations with the previous genetic
characterizations of heritable prion units suggests that
propagons are equivalent to or derived from Sup35-GFP
[PSIþ]
foci. If this relationship is indeed direct, counting propagons
by dispersing colonies formed in the presence of GdnHCl is
likely to yield an underestimate given the clear segregation
bias that we observe for Sup35-GFP
[PSIþ] foci (Figure 4), as
previously suggested [37].
Our work also resolves some of the seemingly conﬂicting
data present in the literature, which necessitated formation
of multiple models for the role of Hsp104 in prion
propagation. One of these controversies is the fate of existing
Sup35-GFP
[PSIþ] upon Hsp104 inhibition. Ness et al. observe
persistent aggregation of existing Sup35 in GdnHCl-treated
[PSI
þ] cultures using a biochemical assay [32]. In contrast, Wu
et al. report disassembly of Sup35-GFP
[PSIþ] complexes upon
Hsp104 inhibition with the same treatment, as assessed by the
accumulation of soluble Sup35-GFP
[PSIþ] using microscopic
approaches [41]. A key consideration in the interpretation of
these studies is the status of Sup35 expression. Wu et al.
monitored the behavior of bulk Sup35-GFP under conditions
of on-going synthesis, whereas Ness et al. focused their studies
on the dynamics of existing Sup35 only [32,41]. By regulating
expression of Sup35-GFP, we resolve these apparent conﬂicts.
Accumulation of soluble Sup35-GFP upon Hsp104 inhibition
only occurs with continued synthesis of the fusion (Figures 4
and 6). Thus, prion complexes are not destabilized upon
Hsp104 loss, but rather become more stable (Figure 4) and
less efﬁcient at incorporating newly synthesized Sup35
(Figure 6). Nonetheless, these static complexes remain
biologically active substrates that are rapidly remodeled to
efﬁcient templates upon Hsp104 reactivation (Figure 7).
Given these observations, [psi
 ] cells must only appear when
existing Sup35
[PSIþ] complexes fail to segregate during cell
division, a prediction at odds with a previous study, which
reported prion curing in arrested cultures [41]. However,
recent studies by Byrne, Cox, and Tuite have uncovered a
high degree of lethality in the strain employed by Wu et al.
upon release from a-factor arrest (L. Byrne, B. S. Cox, and M.
F. Tuite, personal communication). Thus, the reported curing
actually occurred in dividing cultures, but this division was
overlooked due to the extensive, and counterbalancing, cell
death.
Another point of controversy is the role of Hsp104 in the
efﬁciency of Sup35
[psi ] conversion to the prion state. We
observe quantitative inactivation of Sup35
[psi ] upon intro-
duction of Sup35
[PSIþ] in the absence of Hsp104 function in
some cells, as monitored by the appearance of a translation
termination defect (Figure 2B) [43], suggesting that Hsp104 is
not directly required for efﬁcient incorporation. However,
the percentage of cells displaying the prion phenotype is
diminished in Hsp104-inactivated zygotes. This observation is
consistent with a primary role for Hsp104 in the generation
of additional prion templates [6,35,36]. Speciﬁcally, the
converting capacity of some cells falls below the threshold
needed to inactivate the vast majority of soluble Sup35
[psi ]
contributed by the [psi
 ] mating partner when Hsp104 is
inhibited. Since Hsp104 is not available to generate addi-
tional prion seeds, this converting potential is dictated by the
number of propagons present in the cell at the time of
Hsp104 inhibition, a factor that varies widely in individual
cells of a homogenous culture [37]. Consistent with this
interpretation, newly synthesized Sup35-GFP accumulates in
a soluble form soon after Hsp104 inhibition (Figure 6) [32],
coincident with the loss of Sup35-GFP
[PSIþ] remodeling
(Figure 4), and this soluble pool is rapidly inactivated upon
restoration of Hsp104 function and remodeling of existing
Sup35-GFP
[PSIþ] complexes (Figure 7).
An exclusive role for Hsp104 in the generation of new
prion seeds is also compatible with observations in vitro.
Sup35 self-assembly into amyloid ﬁbers is accelerated by the
addition of Hsp104 [13,33], and this effect has been linked to
a steady-state increase in the abundance of an amyloidogenic
intermediate [33,34]. One interpretation of this observation is
that Hsp104 promotes the de novo formation of this species
[33], but an alternate explanation is the Hsp104-dependent
fragmentation of spontaneously arising intermediates. The
incorporation of soluble protein into the smaller complexes
Figure 7. Sup35-GFP
[PSIþ] Complexes, Which Persist after Hsp104
Inhibition, Remain Substrates for This Disaggregase upon Its Reactivation
Wild-type zygotes (SY876 3 74D-694) constitutively expressing SUP35
and GST(UGA)DsRED with existing Sup35-GFP (previously expressed from
PMFA1) were isolated in the presence of GdnHCl and allowed to form
microcolonies. As indicated in the schematic diagram, a portion of this
colony was retained on medium containing GdnHCl (0 h, left), and the
remainder of the colony was transferred to medium lacking GdnHCl (0 h,
right). The cells were imaged again 4 h after the transfer. Representative
DIC, GFP, and DsRed images are shown (n ¼ 9).
doi:10.1371/journal.pbio.0050024.g007
Table 1. Single-Cell Doubling Times
Condition [PSI
þ][ psi
 ]
First Daughter Others First Daughter Others
Untreated 2.0 6 0.7* 1.9 6 0.9 2.4 6 0.9 2.3 6 0.7
GdnHCl 3.7 6 1.1* 2.4 6 0.9 2.7 6 1.3 2.4 6 0.9
Times are in hours. *p , 0.0001
doi:10.1371/journal.pbio.0050024.t001
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apparent steady-state increase in the abundance of this form.
Consistent with this interpretation, Hsp104 preferentially
interacts with low molecular weight oligomers of Sup35 [52],
which are intermediates in ﬁber assembly and disassembly
reactions in vitro [53], and speciﬁcally alters the biophysical
properties of Sup35-GFP
[PSIþ] complexes in vivo (Figure 3).
Thus, the enhanced conversion efﬁciency in vivo and in vitro
is likely to be a secondary consequence of prion-complex
remodeling by Hsp104 (Figure 4) [32].
Loss of Hsp104-dependent remodeling also uncovers bio-
logical consequences for single-cell differences in a super-
ﬁcially homogenous culture. In addition to the variation in
translation termination efﬁciency, [PSI
þ] cells lacking Hsp104
activity display a broader range of doubling times than their
untreated counterparts (Table 1). Again, these distinctions
likely arise from cell-to-cell variation in the number of prion
particles [37] at the time of Hsp104 inhibition, with cells
containing a larger number of prion particles being the most
efﬁcient at converting soluble Sup35, but also the most
detrimental to cellular physiology (Figure 8).
How is remodeling mechanistically accomplished? Hsp104
forms a hexamer with a central pore [26], and previous studies
suggest that Hsp104 functions by threading substrates
through this channel [54,55]. How, then, might this extrusion
lead to Sup35
[PSIþ] remodeling and production of new prion
complexes? Other members of the Clp/Hsp100 family may
provide some insight. For example, ClpX extracts a single
MuA monomer from a DNA-bound tetramer, an event that
destabilizes the remainder of the complex and promotes
dissociation [56–58]. Hsp104 could act similarly on Sup35
[PSIþ]
complexes by unfolding constituent monomers and thereby
fragmenting the now destabilized oligomer. A future chal-
lenge, then, is to determine the contributions of each of these
species, the unfolded monomer and the fragmented oligomer,
to prion propagation and the viability of [PSI
þ] cells.
Materials and Methods
Plasmid construction. pRS306PSUP35SUP35-GFP, pRS303PMFA1
SUP35-GFP, pRS305PLEXAop-GAL1DsRED, pRS306PGPDLEXA-GAL4,
and pRS304GST(UGA)DsRED were previously described [43]. For
pRS304PGPDGSTDsRED, PGPD and the CYC1 terminator were
subcloned as a SacI-KpnI fragment from p424GPD [59] into
pRS304 to create pRS304PGPD. Gluathione-S-transferase (GST) was
PCR ampliﬁed with BamHI and EcoRI linkers, and DsRED with EcoRI
and ClaI linkers, and these two fragments were subcloned into
pRS304PGPD. Primer sequences are available upon request. The
pRS306PHSEHSP104K218TK620T plasmid was kindly provided by S.
Lindquist (Whitehead Institute, Massachusetts Institute of Technol-
ogy). The Msn2-GFP expression plasmid (from PADH1 in YCplac111)
was a kind gift from C. Schueller (Max F Perutz Laboratories,
University and BioCenter Vienna).
Strain construction. Strains used in this study are listed in Table 2
and are derivatives of 74D-694 [20] unless otherwise indicated. KTKT
substitutions were constructed by two-step replacement at the
HSP104 locus using EagI-digested pRS306PHSEHSP104K218TK620T
and veriﬁed by [PSI
þ] loss and sequencing. SUP35-GFP substitutions
were constructed by two-step replacement as previously described
[43]. Plasmids were integrated at the indicated locus by linearizing the
plasmid with the indicated restriction endonuclease within the
nutritional marker: pRS304PGPDGST(UGA)DsRED (TRP1, EcoRV),
pRS303PMFA1SUP35-GFP (HIS3, Eco47III), and pRS304PGPD
GSTDsRED (TRP1, EcoRV).
Zygote isolation. Matings and zygote isolation and conﬁrmation
were performed as previously described [43]. Where indicated,
mating cells were treated with 3 mM GdnHCl for at least 2.5 h
before zygote isolation.
Imaging and digital processing. Cells were observed using a Zeiss
Axioplan 2 (Carl Zeiss, MicroImaging,Oberkochen, Germany) equip-
ped with a 1003 aPlan-FLUAR objective and Hamamatsu-ORCA
camera (Hamamatsu Photonics, Hamamatsu City, Japan) as previ-
ously described [43].
FRAP. FRAP experiments were performed on a Leica TCS SP2
AOBS spectral confocal microscope equipped with an 1003 oil
objective (NA 1.4) and Argon/Helium Neon laser, and data was
captured using the LCS 2.5 software (Leica Microsystems, Wetzlar,
Germany). Frames (163 zoom, 256 3 100 pixels, 2 Airy units) were
collected at 0.13 s bidirectionally at 1,000 Hz and 488-nm excitation
using GFP conditions (500 nm to 560 nm). Laser intensity was set to
3%–4% for collection and 100% for bleaching. The FRAP region of
interest (ROI) was 0.5 lm in diameter and was drawn in the cytoplasm
to encompass soluble Sup35-GFP or foci and to avoid the vacuole.
Software-generated intensity values for the ROI represented the
mean across all pixels. FRAP data were independently corrected for
photobleaching (by comparison with a neighboring region in the
same cell) and normalized against prebleach values as previously
described [60].
Protein analysis. The metabolic stabilities of Sup35-GFP and
Mata2 were analyzed by the post-alkaline extraction protocol [61]
followed by SDS-PAGE and immunoblotting with anti-Pgk1 (Molec-
ular Probes, Eugene, Oregon, United States) and either anti-Mata2o r
anti-Sup35 antiserum as previously described [43,62]. Yeast cultures
were treated with 200-lg/ml cycloheximide at time 0 prior to lysis as
previously described [63].
Doubling-time analysis. Large-budded 5V-H19 cells were micro-
manipulated from exponentially growing liquid YPD cultures onto
solid YPD either containing or lacking 5 mM GdnHCl. Buds were
removed and discarded at the earliest possible point (typically within
the ﬁrst hour). Mothers were then monitored over time, and the point
at which the next daughter could be removed was recorded.
Propagon counts. Individual cells were micromanipulated onto
YPD containing 5 mM GdnHCl and incubated at 30 8C for 7 d.
Colonies were removed from the plate as previously described [37]
Figure 8. Propagon Numbers Correlate with Single-Cell Doubling Times
Wild-type [PSI
þ] haploids (5V-H19) were analyzed for single-cell doubling
time in the presence of GdnHCl and propagon numbers. The percentage
of cells containing more than 1,000 (black), between 1,000 and 500
(gray), and fewer than 500 (white) propagons is indicated.
doi:10.1371/journal.pbio.0050024.g008
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adenine prototrophs were scored. In control experiments, more than
90% of adenine prototrophs were GdnHCl curable.
Supporting Information
Figure S1. Newly Synthesized Sup35-GFP Joins Existing Sup35
Complexes in the Absence of Hsp104 Function
MATa [psi
 ] KTKT haploids (SY751) were mated to MATa haploids
constitutively expressing SUP35-GFP (SY581) as indicated in the
schematic diagram (top). Zygotes from this cross were isolated (left);
existing Sup35-GFP was then photobleached (middle), and the zygote
was allowed to form a microcolony (right). Representative differential
interference contrast (DIC) and GFP images are shown (n ¼ 7).
Found at doi:10.1371/journal.pbio.0050024.sg001 (5.0 MB TIF).
Figure S2. Sup35-GFP
[PSIþ] Complexes Become Immobile after
Inhibition of Hsp104
FRAP time courses for Sup35-GFP
[PSIþ] in wild-type zygotes (SY3603
SY581) in the presence of GdnHCl (white squares, n ¼ 5) are shown.
The black arrow marks the bleach point. Error bars represent
standard error of the mean.
Found at doi:10.1371/journal.pbio.0050024.sg002 (86 KB TIF).
Figure S3. Sup35-GFP
[PSIþ] Remains Detectable in Microcolonies
Lacking Hsp104 Function
MATa [PSI
þ]P MFA1 SUP35-GFP haploids were mated to MATa [psi
 ]
haploids constitutively expressing SUP35 in the presence or absence
of functional Hsp104. For each cross, a zygote (left) and a micro-
colony derived from that zygotes (right) are shown. Representative
images from a wild-type (SY5973SY582; left, n¼15), KTKT (SY5973
SY776; middle, n¼8), or a wild-type cross in the presence of GdnHCl
(SY597 3 SY582; right, n ¼ 11) are shown.
Found at doi:10.1371/journal.pbio.0050024.sg003 (5.5 MB TIF).
Figure S4. Mata2 Is Short-Lived
The metabolic stability of Mata2 was analyzed in MATa 74D-694 cells
after the inhibition of new protein synthesis with cycloheximide.
Lysates from MATa 74D-694 cells, which do not express Mata2, are
included as a negative control. An anti-Pgk1 blot of the same
membrane is shown as a loading control.
Found at doi:10.1371/journal.pbio.0050024.sg004 (1.3 MB TIF).
Figure S5. The Stress-Responsive Transcription Factor Msn2 Is Not
Activated in [PSI
þ] Cells Treated with GdnHCl
Shown are representative DIC and GFP images of MATa 74D-694
[PSI
þ]o rMATa 74D-694 [psi
 ] cells constitutively expressing an Msn2-
G F Pf u s i o np r o t e i nf r o mP ADH1 in untreated, ethanol-treated
(þEtOH), or GdnHCl-treated cultures.
Found at doi:10.1371/journal.pbio.0050024.sg005 (1.5 MB TIF).
Video S1. Sup35-GFP
[PSIþ] Complexes Become Immobile in GdnHCl-
Treated Haploids
Shown is a 5-s video (1 frame/s) of a [PSI
þ] strain constitutively
expressing Sup35-GFP (SY597) after a 24-h treatment with GdnHCl.
Found at doi:10.1371/journal.pbio.0050024.sv001 (8 KB MOV).
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SY751 MATa [psi
 ] ade1–14 trp1–289 his3D200 ura3–52 leu2–3,112 SUP35-GFP HSP104K
218TK620T
This study
SY597 MATa [PSI
þ] ade1–14 trp1–289 his3D200::HIS3::PMFA1SUP35-GFP ura3–52 leu2–3,112 This study
SY582 MATa [psi
 ] ade1–14 trp1–289::TRP1::PGPDGSTDsRED his3D200 ura3–52 leu2–3,112 This study
SY776 MATa [psi
 ] ade1–14 trp1–289::TRP1::PGPDGSTDsRED his3D200 ura3–52 leu2–3,112
HSP104K218TK620T
This study
doi:10.1371/journal.pbio.0050024.t002
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